The Latin America, Middle East and Africa Flow Cytometry Market is expected to witness market growth of 11.4% CAGR during the forecast period (2022-2028).
Traditional gating systems now have an alternative due to recent developments in automated population identification utilizing computational methodologies. Automated identification techniques may aid in locating rare and secret populations. A dimensionality reduction approach called T-Distributed Stochastic Neighbor Embedding (tSNE) is used to visualize complex multi-dimensional data within a two-dimensional map.
An open program called FlowCAP or Flow Cytometry: Critical Assessment of Population Identification Methods, was created as a result of collaborative efforts. Its goals are to provide an impartial means of comparing and evaluating the flow cytometry data clustering methods as well as to establish guidelines regarding the proper use and application of these methods. A strong tool for cell analysis, flow cytometry can be used for a wide range of tasks, from phenotyping to determining the viability and health of cells.
With more than 70% of the worldwide incidence of infection, Sub-Saharan Africa bears a disproportionate burden of HIV. The success of HIV prevention efforts in sub-Saharan Africa could have an impact on the worldwide HIV burden. Despite significant advancements in scaling up antiretroviral therapy, 74% of the 1.5 million AIDS-related fatalities in 2013 occurred in sub-Saharan Africa. In sub-Saharan Africa, where an estimated 6000 new infections are anticipated to develop daily, young women continue to suffer a disproportionate share of the burden.
The Brazil market dominated the LAMEA Flow Cytometry Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $137.3 million by 2028. The Argentina market is experiencing a CAGR of 12% during (2022 - 2028). Additionally, The UAE market is expected to display a CAGR of 11.1% during (2022 - 2028).
Based on Application, the market is segmented into Academic & Clinical and Diagnostic. Based on End User, the market is segmented into Commercial Organizations, Hospitals, Academic Institutions, Medical Schools & Clinical Testing Labs, and Others. Based on Technology, the market is segmented into Cell Based and Bead Based. Based on Component, the market is segmented into Instruments, Reagents & Consumables, Software, and Services. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, BioMérieux S.A., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Miltenyi Biotec B.V. & Co. KG, Sartorius AG, and Sysmex Corporation.
Traditional gating systems now have an alternative due to recent developments in automated population identification utilizing computational methodologies. Automated identification techniques may aid in locating rare and secret populations. A dimensionality reduction approach called T-Distributed Stochastic Neighbor Embedding (tSNE) is used to visualize complex multi-dimensional data within a two-dimensional map.
An open program called FlowCAP or Flow Cytometry: Critical Assessment of Population Identification Methods, was created as a result of collaborative efforts. Its goals are to provide an impartial means of comparing and evaluating the flow cytometry data clustering methods as well as to establish guidelines regarding the proper use and application of these methods. A strong tool for cell analysis, flow cytometry can be used for a wide range of tasks, from phenotyping to determining the viability and health of cells.
With more than 70% of the worldwide incidence of infection, Sub-Saharan Africa bears a disproportionate burden of HIV. The success of HIV prevention efforts in sub-Saharan Africa could have an impact on the worldwide HIV burden. Despite significant advancements in scaling up antiretroviral therapy, 74% of the 1.5 million AIDS-related fatalities in 2013 occurred in sub-Saharan Africa. In sub-Saharan Africa, where an estimated 6000 new infections are anticipated to develop daily, young women continue to suffer a disproportionate share of the burden.
The Brazil market dominated the LAMEA Flow Cytometry Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $137.3 million by 2028. The Argentina market is experiencing a CAGR of 12% during (2022 - 2028). Additionally, The UAE market is expected to display a CAGR of 11.1% during (2022 - 2028).
Based on Application, the market is segmented into Academic & Clinical and Diagnostic. Based on End User, the market is segmented into Commercial Organizations, Hospitals, Academic Institutions, Medical Schools & Clinical Testing Labs, and Others. Based on Technology, the market is segmented into Cell Based and Bead Based. Based on Component, the market is segmented into Instruments, Reagents & Consumables, Software, and Services. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, BioMérieux S.A., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Miltenyi Biotec B.V. & Co. KG, Sartorius AG, and Sysmex Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Application- Academic & Clinical
- Diagnostic
- Commercial Organizations
- Hospitals
- Academic Institutions
- Medical Schools & Clinical Testing Labs
- Others
- Cell Based
- Bead Based
- Instruments
- Reagents & Consumables
- Software
- Services
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Becton Dickinson and Company
- BioMérieux S.A.
- Bio-Rad Laboratories, Inc.
- DiaSorin S.p.A.
- Miltenyi Biotec B.V. & Co. KG
- Sartorius AG
- Sysmex Corporation
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Flow Cytometry Market by Application
Chapter 5. LAMEA Flow Cytometry Market by End User
Chapter 6. LAMEA Flow Cytometry Market by Technology
Chapter 7. LAMEA Flow Cytometry Market by Component
Chapter 8. LAMEA Flow Cytometry Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Becton Dickinson and Company
- BioMérieux S.A.
- Bio-Rad Laboratories, Inc.
- DiaSorin S.p.A.
- Miltenyi Biotec B.V. & Co. KG
- Sartorius AG
- Sysmex Corporation
Methodology
LOADING...
